Companies Related to "Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase" [Most Relevant Company Matches] RSS

10:51 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase" found in our extensive corporate database of over 50,000 company records.

Showing "Comparing Imatinib Standard Dose With Imatinib High Dose" Companies 1–25 of 4,900+

Extremely Relevant

Kræftens Bekæmpelse

To nye former for medicin er på vej i behandlingen af kronisk myeloid leukæmi. De kan tage over, hvis den succesfulde medicin imatinib begynder at svigte, som det sker for ca. hver tiende patient. Medicinen bliver allerede nu tilbudt danske patienter som forsøg.Kræftmedicinen imatinib (Glivec®) har vendt op og ned på prognosen for patienter med kronisk myeloid leukæmi, som rammer ca. 75 dan...

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...


Broncho-Dose Pharmacy provides home-delivered nebulizer medications. Our team of pharmacy specialists provides an outstanding level of customer service to respiratory patients nationwide.


California Endocurietherapy Cancer Center (CET) is the first brachytherapy only center in the United States.Founded by D Jeffrey Demanes M.D. in 1981.Dedicated solely to High Dose Rate brachytherapy (HDR) since 1991.Most experienced HDR brachytherapy center.A training destination for physicians and residents.HDR treatment protocol developmentInnovation in high dose rate brachytherapy and equipment...


Bespak Europe

Bespak, founded more than 40 years ago, has established a reputation as a leading supplier of drug delivery technologies and services to the pharmaceutical and biotechnology industries.The company’s comprehensive capabilities have enabled it to develop proprietary drug delivery devices and technologies, many protected by worldwide patents. These include pressurised metered dose inhalers and actu...

GammaWest Brachytherapy

Brachytherapy is an advanced cancer treatment. The word "brachy" is Greek for "close by" and refers to placing radioactive seeds or sources directly in the tumor. This procedure gives physicians and patients the important advantage of applying a higher dose of radiation directly to the tumor while sparing healthy tissue and surrounding organs. Brachytherapy is a localized, precise, radiation treat...

Glide Pharma

Glide Pharma is a specialty pharmaceutical company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary needle-free solid dose injector, the Glide SDI(R).

Variation Biotechnologies, Inc.

VBI is an emerging leader in the innovative formulation, delivery and development of vaccines. The Company’s powerful, proprietary technology platforms enable thermostable IM and thermostable oral vaccine delivery, creating improved dose equivalent and the potential for dose sparing and adjuvanted vaccines, extending vaccine reach and coverage in established...


Based in Winnipeg, Manitoba and Buffalo Grove, Illinois, ARxIUM delivers best-in-class technology and unparalleled expertise to help pharmacies of all sizes improve safety, productivity and efficiency. The company provides scalable, comprehensive solutions for every segment of the pharmacy market. ARxIUM’s offering includes automated compounding, pack...

ChemGenex Pharmaceuticals Limited

ChemGenex is an oncology focused biopharmaceutical company developing small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. A New Drug Application is under review by the U.S. Food and Drug Administration and a Marketing Authorisation Application is under review by the European Medicines Agency for CML pat...

Lumitron Technologies, Inc.

Based in Irvine, California, Lumitron Technology Inc. was established to develop and commercialize unique X‐ray systems that enable revolutionary new capabilities for high‐fidelity imaging, ultra‐low dose imaging and hyper‐precision radiotherapy.

Cardinal Health Nuclear Pharmacy Services

The Total Solution™ is what you get from America's #1 radiopharmacy services provider. It starts with our Unit Dose Service, which guarantees the highest quality standards and delivery of the right dose, at the right place, at the right time. Then it adds a list of value-added services, including safety solutions, department management, operational excellence, professional consultation and IT so...

CytoSen Therapeutics, Inc.

CytoSen is a private biopharmaceutical company on the front line of advancing clinical development of next generation NK cells with the first scalable, therapeutic platform for high dose, cancer-killing NK cells calibrated to each cancer target while reinforcing immune defenses.

Kedalion Therapeutics, Inc.

Kedalion Therapeutics is a venture-backed, clinical-stage biotechnology company whose mission is to bring to market transformative topical ophthalmic therapies for new and existing indications. Kedalion’s proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable effect with up ...

Amorcyte, Inc.

Amorcyte is a privately held biotechnology company developing cell therapy products to treat cardiovascular disease. Its lead product AMR-001, for the prevention of major adverse cardiac events following acute myocardial infarction (AMI), has completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose. This is the first stem cell trial in AMI eve...

Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

Pharma Two B Ltd.

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. The company focuses on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505(b)(2) approach). The company develops products in two therapeutic areas with ...


ScandiDos is the innovative company that introduced the new QA standard in advanced radiotherapy by moving into the era of 3D and 4D volumetric dosimetry. Founded in 2002 by a group of highly experienced physicists and engineers, ScandiDos grew out of a recognized need for practical clinical solutions for new advanced radiation therapy technologies. ScandiDos mission is to provide complete dosimet...

Jennerex, Inc.

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two mid-stage clinical trials in patients with primary liver cancer -- an international, randomized, Phase 2 dose-response clinical trial, and a Phase 2 study in combina...


MAJOR Pharmaceuticals is one of the leading suppliers of Rx, Unit Dose and OTCs in the Managed Care (non-retail) market.


Dr. David Hill, father, pediatrician and author of “Dad to Dad: Parenting like a Pro,” partnered with PediaCare® to introduce a new single dose children’s medicine product. (Photo: Business Wire)

Anabolic Laboratories, Inc

Anabolic Laboratories, Inc. is a fully licensed, FDA registered pharmaceutical manufacturing facility specializing in solid dose Rx and OTC drugs, as well as custom dietary supplement formulations.

Wavelength Pharmaceuticals

Wavelength is a leading developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel. Wavelength supports a global, blue-chip customer base and has a broad array of products that leverage its specialized manufacturing capabilities (including cytotoxic, steroid and high potency) and core co...

Aplicare, Inc

Founded in 1983 and headquartered in Meriden, CT, Aplicare is a market leader in the formulation, production and packaging of topical antiseptic and personal care products for use in today's professional health care setting. Just recently, we expanded our offering to include sterile procedural kits and trays including the first innovation in procedural kit design in over 30 years. Click here for ...


Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

More From BioPortfolio on "Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase"

Quick Search


Corporate Database Quicklinks